These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 21229977

  • 21. [The chemotherapy of Chagas disease].
    Stoppani AO.
    Medicina (B Aires); 1999; 59 Suppl 2():147-65. PubMed ID: 10668258
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. New oxirane derivatives of 1,4-naphthoquinones and their evaluation against T. cruzi epimastigote forms.
    Carneiro PF, do Nascimento SB, Pinto AV, Pinto Mdo C, Lechuga GC, Santos DO, dos Santos Júnior HM, Resende JA, Bourguignon SC, Ferreira VF.
    Bioorg Med Chem; 2012 Aug 15; 20(16):4995-5000. PubMed ID: 22795899
    [Abstract] [Full Text] [Related]

  • 26. Synthesis, in vitro antitrypanosomal and antibacterial activity of phenoxy, phenylthio or benzyloxy substituted quinolones.
    Ma X, Zhou W, Brun R.
    Bioorg Med Chem Lett; 2009 Feb 01; 19(3):986-9. PubMed ID: 19095449
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Imidazoles from nitroallylic acetates and α-bromonitroalkenes with amidines: synthesis and trypanocidal activity studies.
    Gopi E, Kumar T, Menna-Barreto RF, Valença WO, da Silva Júnior EN, Namboothiri IN.
    Org Biomol Chem; 2015 Oct 14; 13(38):9862-71. PubMed ID: 26288376
    [Abstract] [Full Text] [Related]

  • 30. Rational modification of Mannich base-type derivatives as novel antichagasic compounds: Synthesis, in vitro and in vivo evaluation.
    Paucar R, Martín-Escolano R, Moreno-Viguri E, Azqueta A, Cirauqui N, Marín C, Sánchez-Moreno M, Pérez-Silanes S.
    Bioorg Med Chem; 2019 Sep 01; 27(17):3902-3917. PubMed ID: 31345745
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Synthesis and in vitro trypanocidal activity of some novel iron chelating agents.
    Singh PK, Jones MM, Lane JE, Nesset A, Zimmerman LJ, Ribeiro-Rodrigues R, Richter A, Stenger MR, Carter CE.
    Arzneimittelforschung; 1997 Mar 01; 47(3):311-5. PubMed ID: 9105552
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Novel nitro(triazole/imidazole)-based heteroarylamides/sulfonamides as potential antitrypanosomal agents.
    Papadopoulou MV, Bloomer WD, Rosenzweig HS, Wilkinson SR, Kaiser M.
    Eur J Med Chem; 2014 Nov 24; 87():79-88. PubMed ID: 25240098
    [Abstract] [Full Text] [Related]

  • 36. Pyrazol(in)e derivatives of curcumin analogs as a new class of anti-Trypanosoma cruzi agents.
    Matiadis D, Saporiti T, Aguilera E, Robert X, Guillon C, Cabrera N, Pérez-Montfort R, Sagnou M, Alvarez G.
    Future Med Chem; 2021 Apr 24; 13(8):701-714. PubMed ID: 33648346
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. New Imidazole-Based Compounds Active Against Trypanosoma cruzi.
    Adeyemi OS, Molina MT, Eseola AO, Fonseca-Berzal C, Gómez-Barrio A.
    Comb Chem High Throughput Screen; 2017 Apr 24; 20(1):20-24. PubMed ID: 28071587
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.